Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied Therapeutics Inc.

0.3200
-0.0183-5.41%
Post-market: 0.33940.0194+6.06%16:59 EDT
Volume:1.85M
Turnover:631.71K
Market Cap:45.30M
PE:-1.05
High:0.3535
Open:0.3490
Low:0.3193
Close:0.3383
Loading ...

BRIEF-Applied Therapeutics announces key leadership appointments

Reuters
·
18 Jun

Applied Therapeutics Announces New Leadership Appointments: Evan Bailey as Chief Medical Officer and Dottie Caplan as Executive Vice President

Reuters
·
18 Jun

Applied Therapeutics Announces Key Leadership Appointments

THOMSON REUTERS
·
18 Jun

Applied Therapeutics Inc. Concluded Annual Stockholders Meeting

Reuters
·
12 Jun

Applied announces INSPIRE Phase 2/3 trial primary endpoint not significant

TIPRANKS
·
18 May

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data From Inspire Phase 2/3 Trial of Govorestat in Cmt-Sord in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

THOMSON REUTERS
·
18 May

Applied Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

RBC Capital Keeps Their Hold Rating on Applied Therapeutics (APLT)

TIPRANKS
·
14 May

BRIEF-Applied Therapeutics Q1 Operating Income USD -25.525 Million

Reuters
·
14 May

Applied Therapeutics Q1 Operating Income USD -25.525 Million

THOMSON REUTERS
·
14 May

Applied Therapeutics Q1 EPS USD -0.15

THOMSON REUTERS
·
14 May

Applied Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
05 May

William Blair Sticks to Its Hold Rating for Applied Therapeutics (APLT)

TIPRANKS
·
15 Apr

Press Release: Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

Dow Jones
·
15 Apr

North American Morning Briefing: China Raises Tariffs on U.S. in Latest Salvo

Dow Jones
·
11 Apr

Applied Therapeutics files Form 12b-25 with SEC

TIPRANKS
·
31 Mar

Applied Therapeutics appoints Baumgartner as Chief Regulatory Officer

TIPRANKS
·
19 Mar

Applied Therapeutics Appoints Todd F. Baumgartner, Md, Mph as Chief Regulatory Officer

THOMSON REUTERS
·
19 Mar

Press Release: Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

Dow Jones
·
19 Mar

BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?

Zacks
·
21 Feb